vs

Side-by-side financial comparison of APARTMENT INVESTMENT & MANAGEMENT CO (AIV) and FATE THERAPEUTICS INC (FATE). Click either name above to swap in a different company.

APARTMENT INVESTMENT & MANAGEMENT CO is the larger business by last-quarter revenue ($2.1M vs $1.4M, roughly 1.5× FATE THERAPEUTICS INC). On growth, APARTMENT INVESTMENT & MANAGEMENT CO posted the faster year-over-year revenue change (16.7% vs -26.4%). APARTMENT INVESTMENT & MANAGEMENT CO produced more free cash flow last quarter ($-91.5M vs $-112.0M). Over the past eight quarters, FATE THERAPEUTICS INC's revenue compounded faster (-15.7% CAGR vs -79.5%).

Beach Point Capital Management is an American hedge fund management firm headquartered in Santa Monica, California.The firm focuses on credit related investments.

Insys Therapeutics was an American specialty pharmaceutical company based in Chandler, Arizona in 1990. Its main product was Subsys, a sublingual liquid form of the drug fentanyl. Fentanyl is an extremely fast-acting and powerful opioid used to relieve breakthrough pain in cancer patients, and prescription of fentanyl in the US for such pain usually requires documented failure of more conservative therapies.

AIV vs FATE — Head-to-Head

Bigger by revenue
AIV
AIV
1.5× larger
AIV
$2.1M
$1.4M
FATE
Growing faster (revenue YoY)
AIV
AIV
+43.1% gap
AIV
16.7%
-26.4%
FATE
More free cash flow
AIV
AIV
$20.5M more FCF
AIV
$-91.5M
$-112.0M
FATE
Faster 2-yr revenue CAGR
FATE
FATE
Annualised
FATE
-15.7%
-79.5%
AIV

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AIV
AIV
FATE
FATE
Revenue
$2.1M
$1.4M
Net Profit
$297.3M
Gross Margin
Operating Margin
Net Margin
14155.2%
Revenue YoY
16.7%
-26.4%
Net Profit YoY
2721.3%
37.9%
EPS (diluted)
$2.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AIV
AIV
FATE
FATE
Q4 25
$2.1M
$1.4M
Q3 25
$35.1M
$1.7M
Q2 25
$52.8M
$1.9M
Q1 25
$52.4M
$1.6M
Q4 24
$1.8M
$1.9M
Q3 24
$35.3M
$3.1M
Q2 24
$51.1M
$6.8M
Q1 24
$50.2M
$1.9M
Net Profit
AIV
AIV
FATE
FATE
Q4 25
$297.3M
Q3 25
$283.1M
$-32.3M
Q2 25
$-19.3M
$-34.1M
Q1 25
$-13.9M
$-37.6M
Q4 24
Q3 24
$-21.9M
$-47.7M
Q2 24
$-60.5M
$-38.4M
Q1 24
$-10.2M
$-48.0M
Operating Margin
AIV
AIV
FATE
FATE
Q4 25
Q3 25
51.9%
-1995.1%
Q2 25
56.0%
-1938.5%
Q1 25
55.9%
-2534.1%
Q4 24
Q3 24
50.0%
-1703.9%
Q2 24
55.9%
-665.7%
Q1 24
57.8%
-2652.9%
Net Margin
AIV
AIV
FATE
FATE
Q4 25
14155.2%
Q3 25
805.9%
-1852.4%
Q2 25
-36.6%
-1786.6%
Q1 25
-26.6%
-2309.5%
Q4 24
Q3 24
-62.1%
-1551.0%
Q2 24
-118.3%
-567.4%
Q1 24
-20.3%
-2493.7%
EPS (diluted)
AIV
AIV
FATE
FATE
Q4 25
$2.07
Q3 25
$2.04
$-0.27
Q2 25
$-0.14
$-0.29
Q1 25
$-0.10
$-0.32
Q4 24
Q3 24
$-0.16
$-0.40
Q2 24
$-0.43
$-0.33
Q1 24
$-0.07
$-0.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AIV
AIV
FATE
FATE
Cash + ST InvestmentsLiquidity on hand
$394.9M
$203.7M
Total DebtLower is stronger
$738.6M
Stockholders' EquityBook value
$361.9M
$207.2M
Total Assets
$1.7B
$318.9M
Debt / EquityLower = less leverage
2.04×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AIV
AIV
FATE
FATE
Q4 25
$394.9M
$203.7M
Q3 25
$404.4M
$215.4M
Q2 25
$41.4M
$222.8M
Q1 25
$49.1M
$240.4M
Q4 24
$141.1M
$279.1M
Q3 24
$82.6M
$296.9M
Q2 24
$88.5M
$304.9M
Q1 24
$121.8M
$121.3M
Total Debt
AIV
AIV
FATE
FATE
Q4 25
$738.6M
Q3 25
$828.5M
Q2 25
$1.1B
Q1 25
$1.1B
Q4 24
$829.7M
Q3 24
$1.3B
Q2 24
$1.2B
Q1 24
$1.2B
Stockholders' Equity
AIV
AIV
FATE
FATE
Q4 25
$361.9M
$207.2M
Q3 25
$62.0M
$234.1M
Q2 25
$91.7M
$261.4M
Q1 25
$110.5M
$288.4M
Q4 24
$123.0M
$318.7M
Q3 24
$229.8M
$362.3M
Q2 24
$253.5M
$397.0M
Q1 24
$335.8M
$426.1M
Total Assets
AIV
AIV
FATE
FATE
Q4 25
$1.7B
$318.9M
Q3 25
$2.1B
$343.7M
Q2 25
$1.9B
$371.6M
Q1 25
$1.9B
$398.7M
Q4 24
$2.0B
$440.7M
Q3 24
$2.1B
$495.0M
Q2 24
$2.1B
$528.8M
Q1 24
$2.1B
$569.9M
Debt / Equity
AIV
AIV
FATE
FATE
Q4 25
2.04×
Q3 25
13.37×
Q2 25
11.99×
Q1 25
9.80×
Q4 24
6.75×
Q3 24
5.44×
Q2 24
4.78×
Q1 24
3.52×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AIV
AIV
FATE
FATE
Operating Cash FlowLast quarter
$8.1M
$-106.1M
Free Cash FlowOCF − Capex
$-91.5M
$-112.0M
FCF MarginFCF / Revenue
-4358.6%
-8183.9%
Capex IntensityCapex / Revenue
4744.0%
434.8%
Cash ConversionOCF / Net Profit
0.03×
TTM Free Cash FlowTrailing 4 quarters
$-143.0M
$-199.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AIV
AIV
FATE
FATE
Q4 25
$8.1M
$-106.1M
Q3 25
$8.9M
$-24.4M
Q2 25
$9.7M
$-24.6M
Q1 25
$3.8M
$-33.8M
Q4 24
$47.0M
$-122.9M
Q3 24
$16.4M
$-29.4M
Q2 24
$8.0M
$-32.3M
Q1 24
$21.7M
$-33.4M
Free Cash Flow
AIV
AIV
FATE
FATE
Q4 25
$-91.5M
$-112.0M
Q3 25
$-19.3M
$-26.6M
Q2 25
$-16.8M
$-25.9M
Q1 25
$-15.4M
$-35.0M
Q4 24
$-113.0M
$-123.6M
Q3 24
$-19.6M
$-29.9M
Q2 24
$-28.9M
$-32.4M
Q1 24
$-19.2M
$-33.4M
FCF Margin
AIV
AIV
FATE
FATE
Q4 25
-4358.6%
-8183.9%
Q3 25
-55.0%
-1526.5%
Q2 25
-31.8%
-1360.7%
Q1 25
-29.3%
-2148.9%
Q4 24
-6280.2%
-6645.4%
Q3 24
-55.4%
-973.1%
Q2 24
-56.5%
-477.8%
Q1 24
-38.3%
-1736.9%
Capex Intensity
AIV
AIV
FATE
FATE
Q4 25
4744.0%
434.8%
Q3 25
80.4%
126.5%
Q2 25
50.1%
71.4%
Q1 25
36.7%
73.4%
Q4 24
8890.4%
39.2%
Q3 24
101.9%
16.1%
Q2 24
72.2%
0.8%
Q1 24
81.5%
4.5%
Cash Conversion
AIV
AIV
FATE
FATE
Q4 25
0.03×
Q3 25
0.03×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AIV
AIV

Other Real Estate$2.0M97%
Other$66.0K3%

FATE
FATE

Segment breakdown not available.

Related Comparisons